Fiducial marker placement

PROCEDURE2 trials

Sponsors

National Cancer Institute (NCI), Cedars-Sinai Medical Center

Conditions

Bladder CancerCancerNeoplasmsProstate CancerUrinary Bladder DiseasesUrinary Bladder NeoplasmUrologic Neoplasms

Phase 1

Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment

CompletedNCT00061347

National Cancer Institute (NCI)Cancer, Prostate Cancer

Start: 2003-05-23End: 2018-04-19Updated: 2018-04-23

Unknown Phase

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

RecruitingNCT04442724

Cedars-Sinai Medical CenterBladder Cancer, Neoplasms, Urinary Bladder Diseases +2

Start: 2020-07-01End: 2026-06-30Target: 60Updated: 2025-08-14